Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Operating expenses:
Research and development	$ 30,643	$ 3,062	$ 54,497	$ 8,576
General and administrative	10,129	948	18,365	1,018
Total operating expenses	40,772	4,010	72,862	9,594
Loss from operations	(40,772)	(4,010)	(72,862)	(9,594)
Other income (expense):
Change in fair value of preferred stock tranche liability		(17,210)		(17,030)
Interest income	40		106
Interest expense	(194)		(194)	(27)
Total other expense, net	(154)	(17,210)	(88)	(17,057)
Net loss	$ (40,926)	$ (21,220)	$ (72,950)	$ (26,651)
Net loss per common share, basic and diluted	$ (1.09)	$ (1.95)	$ (1.96)	$ (2.45)
Weighted average common shares outstanding, basic and diluted	37,479,164	10,894,999	37,237,115	10,894,999